The company’s porcine liver is for use with partner OrganOx’s extracorporeal liver cross-circulation (ELC) system in patients ...

Porcine Liver Demonstrated Essential Functional Outputs Throughout the 10-day observation window, the porcine liver exhibited sustained functional activity.Key hepatic functions were confirmed via ...

CAMBRIDGE, Mass. & OXFORD, England, April 15, 2025--eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for ...

The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...

A multidisciplinary team from China has successfully transplanted a gene-modified pig liver into a human recipient diagnosed with brain death. During a 10-day observation period, the porcine liver ...

In the phase 1 trial, up to twenty patients with ACLF and hepatic encephalopathy and ineligible for transplant will be ...

‘It is the first study to demonstrate that a genetically modified porcine liver can survive and exert basic metabolic functions - albumin and bile production - in the human body.’ Liver ...

First-in-human clinical trial will evaluate a novel perfusion system using a genetically engineered porcine liver for critically ill patients with no transplant option CAMBRIDGE, Mass.

eGenesis has gained US Food and Drug Administration (FDA) clearance on an investigational new drug (IND) application for a genetically engineered porcine (pig) liver. The organ is designed for use ...